Mohammad Amini
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 15
- RNA Interference and Gene Delivery 13
- Advanced biosensing and bioanalysis techniques 9
-
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 13
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Ahad Mokhtarzadeh (37 shared papers)Behzad Baradaran (21 shared papers)Xiao Yu Wu (14 shared papers)Andrew M. Rauth (12 shared papers)Behzad Baradaran (24 shared papers)Fatemeh Oroojalian (8 shared papers)Cláudia R. Gordijo (7 shared papers)Reza Mohammadzadeh (3 shared papers)
- Journals
- Life Sciences (5 papers)Pharmaceutical Development and Technology (3 papers)Gene (3 papers)Advanced Functional Materials (3 papers)European Journal of Pharmacology (3 papers)
- Partner nations
- IranCanadaUnited States
In The Last Decade
Mohammad Amini
85 papers receiving 2.3k citations
Mohammad Amini's Hit Papers
Peers
Comparison fields: 5 of 117
- Biomaterials 509
- Cancer Research 460
- Biomedical Engineering 821
- Molecular Biology 950
- Pharmaceutical Science 76
Countries citing papers authored by Mohammad Amini
This map shows the geographic impact of Mohammad Amini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Amini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Amini more than expected).
Fields of papers citing papers by Mohammad Amini
This network shows the impact of papers produced by Mohammad Amini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Amini. The network helps show where Mohammad Amini may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Amini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in nanoparticle-based photothermal therapy for breast cancer Hit paper breakdown → | 2022 | 219 |
| 2 | 2015 | 193 | |
| 3 | 2021 | 168 | |
| 4 | 2016 | 100 | |
| 5 | 2019 | 84 | |
| 6 | 2018 | 81 | |
| 7 | 2010 | 76 | |
| 8 | 2022 | 74 | |
| 9 | 2022 | 71 | |
| 10 | 2015 | 62 | |
| 11 | 2020 | 62 | |
| 12 | 2018 | 58 | |
| 13 | 2014 | 56 | |
| 14 | 2012 | 55 | |
| 15 | 2021 | 42 | |
| 16 | 2019 | 41 | |
| 17 | 2020 | 41 | |
| 18 | 2018 | 40 | |
| 19 | 2017 | 36 | |
| 20 | 2023 | 36 |
About Mohammad Amini
Mohammad Amini is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Oncology and Biomaterials, having authored 88 papers that have together received 2.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (15 papers), RNA Interference and Gene Delivery (13 papers), Cancer-related molecular mechanisms research (13 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced biosensing and bioanalysis techniques (9 papers), Nanoparticle-Based Drug Delivery (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Biomaterials (509 citations), Cancer Research (460 citations), Biomedical Engineering (821 citations), Molecular Biology (950 citations) and Pharmaceutical Science (76 citations). Mohammad Amini has collaborated with scholars based in Iran, Canada and United States. Frequent co-authors include Ahad Mokhtarzadeh, Behzad Baradaran, Xiao Yu Wu, Andrew M. Rauth, Behzad Baradaran, Fatemeh Oroojalian, Cláudia R. Gordijo, Reza Mohammadzadeh, Azusa Maeda and Ralph S. DaCosta. Their work appears in journals such as Life Sciences, Pharmaceutical Development and Technology, Gene, Advanced Functional Materials and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.